N Colombo, C Sessa, A du Bois, J Ledermann, W G McCluggage, I McNeish, P Morice, S Pignata, I Ray-Coquard, I Vergote, T Baert, I Belaroussi, A Dashora, S Olbrecht, F Planchamp, D Querleu. Ann Oncol 2019
Times Cited: 291
Times Cited: 291
Kathryn P Pennington, Tom Walsh, Maria I Harrell, Ming K Lee, Christopher C Pennil, Mara H Rendi, Anne Thornton, Barbara M Norquist, Silvia Casadei, Alexander S Nord, Kathy J Agnew, Colin C Pritchard, Sheena Scroggins, Rochelle L Garcia, Mary-Claire King, Elizabeth M Swisher. Clin Cancer Res 2014
Times Cited: 547
Times Cited: 547
List of shared articles
Times cited
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
I Vergote, A González-Martín, I Ray-Coquard, P Harter, N Colombo, P Pujol, D Lorusso, M R Mirza, B Brasiuniene, R Madry,[...]. Ann Oncol 2022
I Vergote, A González-Martín, I Ray-Coquard, P Harter, N Colombo, P Pujol, D Lorusso, M R Mirza, B Brasiuniene, R Madry,[...]. Ann Oncol 2022
Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer Part 2: Medical Perspectives.
Stanislas Quesada, Michel Fabbro, Jérôme Solassol. Cancers (Basel) 2022
Stanislas Quesada, Michel Fabbro, Jérôme Solassol. Cancers (Basel) 2022
Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations.
Stanislas Quesada, Michel Fabbro, Jérôme Solassol. Cancers (Basel) 2022
Stanislas Quesada, Michel Fabbro, Jérôme Solassol. Cancers (Basel) 2022
Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing.
Vida Stegel, Ana Blatnik, Erik Škof, Vita Šetrajčič Dragoš, Mateja Krajc, Brigita Gregorič, Petra Škerl, Ksenija Strojnik, Gašper Klančar, Marta Banjac,[...]. Cancers (Basel) 2022
Vida Stegel, Ana Blatnik, Erik Škof, Vita Šetrajčič Dragoš, Mateja Krajc, Brigita Gregorič, Petra Škerl, Ksenija Strojnik, Gašper Klančar, Marta Banjac,[...]. Cancers (Basel) 2022
Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research.
James Clark, Christina Fotopoulou, Paula Cunnea, Jonathan Krell. Front Oncol 2022
James Clark, Christina Fotopoulou, Paula Cunnea, Jonathan Krell. Front Oncol 2022
Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients.
Caterina Fumagalli, Ilaria Betella, Alessandra Rappa, Maria di Giminiani, Michela Gaiano, Luigi Antonio De Vitis, Benedetta Zambetti, Davide Vacirca, Francesco Multinu, Konstantinos Venetis,[...]. Cancers (Basel) 2022
Caterina Fumagalli, Ilaria Betella, Alessandra Rappa, Maria di Giminiani, Michela Gaiano, Luigi Antonio De Vitis, Benedetta Zambetti, Davide Vacirca, Francesco Multinu, Konstantinos Venetis,[...]. Cancers (Basel) 2022
Genomic profiling of platinum-resistant ovarian cancer: The road into druggable targets.
Alexandre André Balieiro Anastácio da Costa, Glauco Baiocchi. Semin Cancer Biol 2021
Alexandre André Balieiro Anastácio da Costa, Glauco Baiocchi. Semin Cancer Biol 2021
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆.
X H Wu, J Q Zhu, R T Yin, J X Yang, J H Liu, J Wang, L Y Wu, Z L Liu, Y N Gao, D B Wang,[...]. Ann Oncol 2021
X H Wu, J Q Zhu, R T Yin, J X Yang, J H Liu, J Wang, L Y Wu, Z L Liu, Y N Gao, D B Wang,[...]. Ann Oncol 2021